Loading...
8 Russia Diabetes Care Drugs Reports
Country Covered: Russia
Study Period: 2019 - 2029
Major Players: Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company
Country Covered: Russia
Study Period: 2018 - 2029
Major Players: AstraZeneca, Eli Lilly, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis
Country Covered: Russia
Study Period: 2018 - 2029
Major Players: Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Biocon
Country Covered: Russia
Study Period: 2018 - 2029
Major Players: Eli Lilly, Astrazeneca, Novo Nordisk, Sanofi, Boehringer Ingelheim
Country Covered: Russia
Study Period: 2018 - 2029
Major Players: Teva, Bristol-Myers Squibb, AstraZeneca, Sanofi Aventis, Merck and Co.
Country Covered: Russia
Study Period: 2019 - 2029
Major Players: Sanofi, Eli Lilly, Astrazeneca, Astellas, Janseen
Country Covered: Russia
Study Period: 2018 - 2029
Major Players: Eli Lilly and Company, Astellas Pharma Inc., Sanofi S.A., Janssen Pharmaceuticals, AstraZeneca
Country Covered: Russia
Study Period: 2019- 2029
Major Players: Boehringer Ingelheim, Sanofi Aventis, Merck & Co., Inc., Eli Lilly and Company, Novo Nordisk A/S